Elsevier

Gene

Volume 536, Issue 1, 15 February 2014, Pages 129-134
Gene

The association of FOXO3A gene polymorphisms with serum FOXO3A levels and oxidative stress markers in vitiligo patients

https://doi.org/10.1016/j.gene.2013.11.055Get rights and content

Highlights

  • We firstly studied FOXO3A SNPs, FOXO3A levels and protein oxidation in vitiligo.

  • The rs4946936 of FOXO3A gene showed significant association with vitiligo.

  • We found that decreased FOXO3A levels and increased AOPP levels in vitiligo.

Abstract

Vitiligo is an acquired epidermal pigment loss of the skin. Oxidative stress is one of the major theories in the pathophysiology of vitiligo. FOXO3A is the forkhead members of the class O (FOXO) transcription factors, and plays an important role in cell cycle regulation, apoptosis, oxidative stress, and DNA repair. The aim of our study was to investigate FOXO3A gene polymorphisms and FOXO3A protein levels, activities of superoxide dismutase (SOD) and catalase antioxidant enzymes in vitiligo patients and healthy controls. Moreover, the level of plasma advanced oxidation protein products (AOPP) in subjects was evaluated to understand the possible role of protein oxidation in disease etiology. Study groups included 82 vitiligo patients and 81 unrelated healthy controls. FOXO3A polymorphisms were determined using polymerase chain reaction–restriction fragment length polymorphism method. FOXO3A levels and catalase activity were measured by ELISA whereas AOPP levels and SOD activity was measured by spectrophotometric analysis. We found a significant relationship between rs4946936 polymorphism of FOXO3A gene and vitiligo/active vitiligo patients (p = 0.017; p = 0.019 respectively), but not for rs2253310 (p > 0.05). SOD activity and AOPP levels of vitiligo patient were increased compared with control group, whereas FOXO3A levels and catalase enzyme activity of vitiligo patient were decreased compared with control group (p < 0.05). Our study indicates that rs4946936 of FOXO3A gene may associate susceptibility of vitiligo, especially active vitiligo. Moreover, our results confirm that oxidative stress may play a role in the pathophysiology of vitiligo. Further studies with larger samples are required to elucidate the role of FOXO3A in vitiligo.

Introduction

Vitiligo is an acquired depigmenting disease characterized by milky white patches of skin due to local loss of the epidermal melanocytes (Halder and Chappell, 2009, Huang et al., 2002). It occurs with a frequency of 0.1–2% worldwide (Ortonne, 2008). Although its pathophysiology is still unknown, diverse theories have been proposed, including autoimmune, neural, oxidative stress, apoptosis, and genetic factors (Passeron and Ortonne, 2005). Recent studies have suggested that oxidative stress might play a prominent role in the pathogenesis of vitiligo (Maresca et al., 1997, Schallreuter et al., 1991, Schallreuter et al., 1994, Schallreuter et al., 1999). Oxidative stress is defined as a disruption of the delicate balance between the formation of reactive oxygen species (ROS) and the antioxidant defense system (Sies, 1991). ROS, especially superoxide anions and hydrogen peroxide (H2O2), can cause lipid peroxidation and protein and DNA oxidation, as well as alter apoptotic pathways, thereby inducing cellular injury. It has been suggested that some enzyme defects during melanogenesis might cause oxidative stress, with a consequent accumulation of H2O2 (Jimbow et al., 2001). Several clinical studies have demonstrated increased H2O2 levels and decreased antioxidant enzyme activities in vitiligo patients (Beazley et al., 1999, Hazneci et al., 2005, Koca et al., 2004, Schallreuter et al., 1991); high levels of H2O2 are thought to trigger melanocyte degeneration in patients with vitiligo. It has been suggested that ROS such as H2O2 stimulate apoptosis through activation of signaling molecules, including protein kinase C and c-Jun-N-terminal kinase (Essers et al., 2004).

Genetic factors are also thought to have an important role in the etiology of vitiligo (Imran et al., 2012). Recently, single-nucleotide polymorphisms (SNPs) of several candidate genes, including PTPN22, NLRP1, ESR1, FOXP1, CAT, COMT, TLR-2, and TLR-4, were reported to be associated with vitiligo susceptibility (Casp et al., 2002, Imran et al., 2012, Karaca et al., 2013, Shajil et al., 2006). Forkhead box class O (FOXO) proteins are a subclass family of the Forkhead box (FOX) transcription factors, including FOXO1, FOXO3A, FOXO4, and FOXO6, which play a crucial role in diverse cellular processes such as cell cycle regulation, apoptosis, oxidative stress and DNA repair (Brunet et al., 1999, Furukawa-Hibi et al., 2005). Studies have shown that FOXO3A have important roles in the regulation of oxidative stress. Activation of FOXO3A has been shown to induce gene expression of manganese superoxide dismutase (MnSOD) and catalase antioxidant enzymes (Kops et al., 2002, Nemoto and Finkel, 2002), as well as prevent cell integrity against genotoxic agents H2O2 and UV irradiation (Brunet et al., 2004, Klagge et al., 2011). The human FOXO3A gene is located at chromosomal position 6q21 and is comprised of three exons and two introns (Anderson et al., 1998). Thus far, functional SNPs of FOXO3A have been found to be associated with longevity, obesity, and bipolar disorders (Anselmi et al., 2009, Flachsbart et al., 2009, Kim et al., 2006; Li, 2008; Magno et al., 2001, Willcox et al., 2008). However, to the best of our knowledge, there have been no reports regarding the relationship between FOXO3A genetic variants and the risk of vitiligo.

Taking into account the possible effects of oxidative stress and apoptosis in the pathophysiology of vitiligo, we hypothesized that FOXO3A genetic variants might be associated with risk of vitiligo. For this reason, we investigated two functional SNPs (rs2253310, rs4946936) in the FOXO3A gene, as well as its protein levels and superoxide dismutase (SOD) and catalase antioxidant enzyme activities in vitiligo patients and healthy controls. In addition, plasma advanced oxidation protein product (AOPP) levels were evaluated in an effort to understand the possible role of protein oxidation in the etiology of vitiligo.

Section snippets

Methods

This study was approved by the Ethics Committee of the Bulent Ecevit University Faculty of Medicine (protocol no; 2011-63-17/05) and performed in accordance with the guidelines of the Declaration of Helsinki; written informed consent was obtained from all the subjects. Eighty-two vitiligo patients and 81 matched healthy controls, all recruited from the Department of Dermatology at Bulent Ecevit University Hospital, were included in the study. The healthy controls displayed no clinical evidence

Clinical and biochemical variables

The clinical characteristics of the vitiligo patients and the healthy controls are shown in Table 1. No statistically significant differences in median ages between the two groups were observed (p > 0.05). SOD activity and AOPP levels were determined to be significantly higher in the patients with vitiligo than in the healthy control group (p < 0.001; Table 3). Catalase activity and FOXO3A levels of the patients with vitiligo were lower than those of the control group (p < 0.001; Table 3).

Genotype and allele frequencies

The

Discussion

Oxidative stress and genetic predisposition is thought to play an important role in the pathogenesis of vitiligo. To the best of our knowledge, our study is the first to evaluate the association of FOXO3A gene polymorphisms, FOXO3A levels, and protein oxidation with the pathophysiology of vitiligo. We also investigated activities of the main antioxidant enzymes in vitiligo patients and healthy subjects by measuring SOD and catalase activities. In this study, we demonstrated that rs4946936 of

Conflict of interest

The authors report that there is no conflict of interests.

Acknowledgments

This study was supported by the Research Fund of the University Mugla Sitki Kocman (No: 2011/68). We would also like to thank Dr. Seda Sevinc KAYA for her assistance in collecting patient samples.

References (50)

  • K.U. Schallreuter et al.

    Low catalase levels in the epidermis of patients with vitiligo

    J Invest Dermatol

    (1991)
  • K.U. Schallreuter

    In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patientswith vitiligo and its successful removal by a UVB-activated pseudocatalase

    J Investing Dermatol Symp Proc

    (1999)
  • V. Witko-Sarsat

    Advanced oxidation protein products as a novel marker of oxidative stress in uremia

    Kidney Int

    (1996)
  • S. Yalcin

    Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells

    J Biol Chem

    (2008)
  • C.V. Anselmi

    Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study

    Rejuvenation Res

    (2009)
  • K. Banasik

    The FOXO3A rs2802292 G-allele associates with improved peripheral and hepatic insulin sensitivity and increased skeletal muscle-FOXO3A mRNA expression in twins

    J Clin Endocrinol Metab

    (2011)
  • W.D. Beazley et al.

    Serum selenium levels and blood glutathione peroxidase activities in vitiligo

    Br J Dermatol

    (1999)
  • A. Brunet

    Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase

    Science

    (2004)
  • C.B. Casp et al.

    Genetic association of the catalase gene (CAT) with vitiligo susceptibility

    Pigment Cell Res

    (2002)
  • B.C. Courtney et al.

    Genetic association of the catalase gene (CAT) with vitiligo susceptibility

    Pigment Cell Res

    (2002)
  • M.A. Essers

    FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK

    EMBO J

    (2004)
  • F. Flachsbart

    Association of FOXO3A variation with human longevity confirmed in German centenarians

    Proc Natl Acad Sci U S A

    (2009)
  • Y. Furukawa-Hibi et al.

    FOXO transcription factors in cell-cycle regulation and the response to oxidative stress

    Antioxid Redox Signal

    (2005)
  • R.M. Halder et al.

    Vitiligo update

    Semin Cutan Med Surg

    (2009)
  • M. Hanasand et al.

    Improved detection of advanced oxidation protein products in plasma

    Clin Chim Acta

    (2012)
  • Cited by (0)

    View full text